Palvella Therapeutics (PVLA) Depreciation and Depletion (2014 - 2020)
Palvella Therapeutics (PVLA) reported Depreciation and Depletion of $530000.0 for Q2 2020, up 1161.9% year-over-year from $42000.0 in Q3 2019, and up 56.34% on a QoQ basis from $339000.0 in Q1 2020.
Palvella Therapeutics (PVLA) has 7 years of Depreciation and Depletion data on file, last reported at $530000.0 in Q2 2020.
- Quarterly Depreciation and Depletion rose 1161.9% year-over-year to $530000.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $1.3 million (up 136.59% YoY) and the FY2023 annual result came in at $1.8 million, down 21.74% from the prior year.
- Depreciation and Depletion improved to $530000.0 in Q2 2020 per PVLA's latest filing, from $339000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $530000.0 in Q2 2020 and bottomed at -$11764.0 in Q2 2016.
- The 5-year median for Depreciation and Depletion is $132000.0 (2018), against an average of $157666.7.
- The widest annual swing landed in 2016, when Depreciation and Depletion plunged 115.39%; it then jumped 1161.9% in 2020.
- Tracing PVLA's Depreciation and Depletion over 5 years: stood at $224613.0 in 2016, then plunged by 55.03% to $101000.0 in 2017, then surged by 93.07% to $195000.0 in 2018, then gained by 19.49% to $233000.0 in 2019, then soared by 127.47% to $530000.0 in 2020.
- Per Business Quant, the three latest PVLA Depreciation and Depletion figures stand at $530000.0 (Q2 2020), $339000.0 (Q1 2020), and $233000.0 (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 530,000.00 |
| Jun 30, 2020 | 530,000.00 |
| Mar 31, 2020 | 339,000.00 |
| Mar 31, 2020 | 339,000.00 |
| Dec 31, 2019 | 233,000.00 |
| Dec 31, 2019 | 233,000.00 |
| Sep 30, 2019 | 159,000.00 |
| Sep 30, 2019 | 159,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Mar 31, 2019 | 166,000.00 |
| Mar 31, 2019 | 166,000.00 |
| Dec 31, 2018 | 195,000.00 |
| Dec 31, 2018 | 195,000.00 |
| Sep 30, 2018 | 130,000.00 |
| Sep 30, 2018 | 130,000.00 |
| Jun 30, 2018 | 141,000.00 |
| Jun 30, 2018 | 141,000.00 |
| Mar 31, 2018 | 134,000.00 |
| Mar 31, 2018 | 134,000.00 |
| Dec 31, 2017 | 101,000.00 |
| Dec 31, 2017 | 101,000.00 |
| Sep 30, 2017 | 55,000.00 |
| Sep 30, 2017 | 55,000.00 |
| Jun 30, 2017 | 113,000.00 |
| Jun 30, 2017 | 113,000.00 |
| Mar 31, 2017 | 100,000.00 |
| Mar 31, 2017 | 100,000.00 |
| Dec 31, 2016 | 224,613.00 |
| Dec 31, 2016 | 224,613.00 |
| Sep 30, 2016 | 92,630.00 |
| Sep 30, 2016 | 92,630.00 |
| Jun 30, 2016 | -11,764.00 |
| Jun 30, 2016 | -11,764.00 |
| Mar 31, 2016 | 94,521.00 |
| Mar 31, 2016 | 94,521.00 |
| Dec 31, 2015 | 73,840.00 |
| Dec 31, 2015 | 73,840.00 |
| Sep 30, 2015 | 79,511.00 |
| Sep 30, 2015 | 79,511.00 |
| Jun 30, 2015 | 76,438.00 |
| Jun 30, 2015 | 76,438.00 |
| Mar 31, 2015 | 78,117.00 |
| Mar 31, 2015 | 78,117.00 |
| Sep 30, 2014 | 278,852.00 |
| Sep 30, 2014 | 278,852.00 |
| Jun 30, 2014 | 189,463.00 |
| Jun 30, 2014 | 189,463.00 |
| Mar 31, 2014 | 95,549.00 |
| Mar 31, 2014 | 95,549.00 |